Two birds, one BiTE: blinatumomab achieves concurrent B-ALL control and EBV clearance in post-HSCT patients: two

Yawei Zhang1, Zebin Luo1, Miner Gu1

  • 1Division of Hematology/Oncology, Children's Hospital, National Clinical Research Center for Children and Adolescents' Health and Diseases, Zhejiang University School of Medicine, No. 3333 Binsheng Road, Hangzhou, 310052, People's Republic of China.

BMC Pediatrics
|March 24, 2026
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos